Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Respir Res. 2018 Feb 13;19(1):29. doi: 10.1186/s12931-018-0735-x.
ATP-regulated potassium channels (KATP) regulate pulmonary vascular tone and are involved in hypoxic pulmonary vasoconstriction (HPV). In patients with inflammation like sepsis or ARDS, HPV is impaired, resulting in a ventilation-perfusion mismatch and hypoxia. Since increase of vascular KATP channel Kir6.1 has been reported in animal models of endotoxemia, we studied the expression and physiological effects of Kir6.1 in murine endotoxemic lungs. We hypothesized that inhibition of overexpressed Kir6.1 increases HPV in endotoxemia.
Mice (C57BL/6; n = 55) with (n = 27) and without (n = 28) endotoxemia (35 mg/kg LPS i.p. for 18 h) were analyzed for Kir6.1 gene as well as protein expression and HPV was examined in isolated perfused mouse lungs with and without selective inhibition of Kir6.1 with PNU-37883A. Pulmonary artery pressure (PAP) and pressure-flow curves during normoxic (FO 0.21) and hypoxic (FO 0.01) ventilation were obtained. HPV was quantified as the increase in perfusion pressure in response to hypoxic ventilation in mmHg of baseline perfusion pressure (ΔPAP) in the presence and absence of PNU-37883A.
Endotoxemia increases pulmonary Kir6.1 gene (+ 2.8 ± 0.3-fold) and protein expression (+ 2.1 ± 0.3-fold). Hypoxia increases HPV in lungs of control animals, while endotoxemia decreases HPV (∆PAP control: 9.2 ± 0.9 mmHg vs. LPS: 3.0 ± 0.7 mmHg, p < 0.05, means ± SEM). Inhibition of Kir6.1 with 1 μM PNU-37883A increases HPV in endotoxemia, while not increasing HPV in controls (∆PAP PNU control: 9.3 ± 0.7 mmHg vs.
8.3 ± 0.9 mmHg, p < 0.05, means ± SEM).
Endotoxemia increases pulmonary Kir6.1 gene and protein expression. Inhibition of Kir6.1 augments HPV in murine endotoxemic lungs.
三磷酸腺苷调节钾通道(KATP)调节肺血管张力,并参与低氧性肺血管收缩(HPV)。在患有炎症的患者中,如脓毒症或 ARDS,HPV 受损,导致通气-灌注不匹配和缺氧。由于在动物模型的内毒素血症中已经报道了血管 KATP 通道 Kir6.1 的增加,我们研究了 Kir6.1 在鼠内毒素血症肺中的表达和生理效应。我们假设抑制过表达的 Kir6.1 会增加内毒素血症中的 HPV。
分析了(n = 27)和未(n = 28)接受内毒素血症(腹腔内注射 35mg/kg LPS 18 小时)的 C57BL/6 小鼠的 Kir6.1 基因和蛋白表达,并在存在和不存在选择性抑制 Kir6.1 用 PNU-37883A 的情况下检查分离灌注的小鼠肺中的 HPV。在常氧(FO 0.21)和低氧(FO 0.01)通气期间获得肺动脉压(PAP)和压力-流量曲线。在存在和不存在 PNU-37883A 的情况下,HPV 被量化为低氧通气时对基础灌注压的灌注压增加(mmHg)(ΔPAP)。
内毒素血症增加了肺 Kir6.1 基因(+ 2.8 ± 0.3 倍)和蛋白表达(+ 2.1 ± 0.3 倍)。缺氧增加了对照动物的 HPV,而内毒素血症降低了 HPV(ΔPAP 对照:9.2 ± 0.9mmHg 对 LPS:3.0 ± 0.7mmHg,p < 0.05,平均值 ± SEM)。用 1μM PNU-37883A 抑制 Kir6.1 增加了内毒素血症中的 HPV,而在对照组中则没有增加 HPV(ΔPAP PNU 对照:9.3 ± 0.7mmHg 对 PNU LPS:8.3 ± 0.9mmHg,p < 0.05,平均值 ± SEM)。
内毒素血症增加了肺 Kir6.1 基因和蛋白表达。抑制 Kir6.1 增强了鼠内毒素血症肺中的 HPV。